| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7699609 | ORAPHARMA | Dispensing apparatus and cartridge with deformable tip |
Mar, 2022
(1 year, 6 months ago) | |
| US6682348 | ORAPHARMA | Dispensing apparatus and cartridge |
Mar, 2022
(1 year, 6 months ago) | |
Arestin is owned by Orapharma.
Arestin contains Minocycline Hydrochloride.
Arestin has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Arestin are:
- US7699609
- US6682348
Arestin was authorised for market use on 16 February, 2001.
Arestin is available in powder, extended release;dental dosage forms.
The generics of Arestin are possible to be released after 29 March, 2022.
Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient
Market Authorisation Date: 16 February, 2001
Treatment: NA
Dosage: POWDER, EXTENDED RELEASE;DENTAL
ARESTIN family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic